Evidence map›Paper›PMID 37493163›Full record

ReviewCurrent drug discovery technologies2024

The Nanotech Potential of Curcumin in Pharmaceuticals: An Overview.

Sagar Pardeshi, Popat Mohite, Tanavirsing Rajput, Abhijeet Puri

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current drug discovery technologies, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sagar PardeshiDepartment of Pharmaceutics AET's St. John Institute of Pharmacy and Research, Manor Road, Palghar, Maharashtra- 401404, India.ORCID 0000-0003-1359-5907
Popat MohiteDepartment of Pharmaceutical Chemistry, AET's St. John Institute of Pharmacy and Research, Manor Road, Palghar, Maharashtra-401404, India.
Tanavirsing RajputDepartment of Pharmaceutical Chemistry, AET's St. John Institute of Pharmacy and Research, Manor Road, Palghar, Maharashtra-401404, India.ORCID 0000-0002-1635-0238
Abhijeet PuriDepartment of Pharmacognosy, AET's St. John Institute of Pharmacy and Research, Manor Road, Palghar, Maharashtra-401404, India.ORCID 0000-0002-4537-4909

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is safe to use Curcumin as a cosmetic and therapeutic ingredient in pharmaceutical products. For the uses mentioned above and for fundamental research, it is essential to obtain pure Curcumin from plant sources. There is a requirement for effective extraction and purification techniques that adhere to green chemistry standards for efficiency improvement, process safety, and environmental friendliness. Several outstanding studies have looked into the extraction and purification of Curcumin. This review thoroughly covers the currently available curcumin extraction, synthesis, and transformation techniques. Additionally, Curcumin's poor solubility and low absorption in the human body have limited its potential for pharmaceutical use. However, recent developments in novel curcumin formulations utilizing nanotechnology delivery methods have provided new approaches to transport and maximize the human body's curcumin absorption efficiency. In this review, we explore the various curcumin nanoformulations and the potential medicinal uses of nano curcumin. Additionally, we review the necessary future research directions to recommend Curcumin as an excellent therapeutic candidate.

Indexed as

CurcuminAnimalsDrug Delivery SystemsHumansNanoparticlesNanotechnologyCurcuminanticancerantioxidant.bioavailabilityCurcuminextractionnano curcumin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.